Kuo-Tung Tang

Dr. Kuo-Tung Tang

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
KTKuo-Tung Tang
Kuo-Tung Tang
Lim Chih-ChenLim Chih-Chen
Lim Chih-Chen
Lim Chih-ChenLim Chih-Chen
Lim Chih-Chen
JWJou-Hsuan Wang
Jou-Hsuan Wang
STSenwei Tsai
Senwei Tsai
Kurarinone is a flavanone, extracted from Sophora flavescens Aiton, with multiple biological effects. Here, we determine the therapeutic potential of kurarinone and elucidate the interplay between kurarinone and the autoimmune disease rheumatoid arthritis (RA). Arthritis was recapitulated by induction of bovine collagen II (CII) in DBA/1 mice as a collagen-induced arthritis (CIA) model. After the establishment of the CIA, kurarinone was given orally from day 21 to 42 (100 mg/kg/day) followed by determination of the severity based on a symptom scoring scale and with histopathology. Levels of cytokines, anti-CII antibodies, and the proliferation and lineages of T cells from the draining lymph nodes were measured using ELISA and flow cytometry, respectively. The expressional changes, including STAT1, STAT3, Nrf2, KEAP-1, and heme oxygenase-1 (HO-1) changes in the paw tissues, were evaluated by Western blot assay. Oxidative stress featured with malondiadehyde (MDA) and hydrogen peroxide (H2O2) activities in paw tissues were also evaluated. Results showed that kurarinone treatment reduced arthritis severity of CIA mice, as well as their levels of proinflammatory cytokines, TNF-α, IL-6, IFN-γ, and IL-17A, in the serum and paw tissues. T cell proliferation was also reduced by kurarinone even under the stimulation of CII and anti-CD3 antibody. In addition, kurarinone reduced STAT1 and STAT3 phosphorylation and the proportions of Th1 and Th17 cells in lymph nodes. Moreover, kurarinone suppressed the production of MDA and H2O2. All while promoting enzymatic activities of key antioxidant enzymes, SOD and GSH-Px. In the paw tissues, upregulation of Nrf-2 and HO-1, and downregulation of KEAP-1 were observed. Overall, kurarinone showed an anti-inflammatory effect by inhibiting Th1 and Th17 cell differentiation and an antioxidant effect exerted in part through activating the Nrf-2/KEAP-1 pathway. These beneficial effects in CIA mice contributed to the amelioration of their arthritis, indicating that kurarinone might be an adjunct treatment option for rheumatoid arthritis.

15 April 2020 in BMJ Open Gastroenterology
Verified
Journal Article
Open access
PDF file
KTKuo-Tung Tang
Kuo-Tung Tang
JDJean-François Dufour
Jean-François Dufour
PCPo-Hung Chen
Po-Hung Chen
RHRuben Hernaez
Ruben Hernaez
SHSusan Hutfless
Susan Hutfless
Objective Elevated tumour necrosis factor (TNF)-α has been implicated in the progression of liver fibrosis and pathogenesis of non-alcoholic fatty liver disease (NAFLD). We aim to investigate the impact of anti-TNF-α agents on the development of cirrhosis and NAFLD. Design This retrospective cohort study used a US claims database between 1 January 2010 and 31 December 2016. We identified adult patients with ankylosing spondylitis, inflammatory bowel disease, psoriatic arthritis or rheumatoid arthritis. Anti-TNF-α agents of interest included adalimumab, certolizumab, etanercept, golimumab and infliximab. The primary composite outcome was the development of new-onset cirrhosis, NAFLD or non-alcoholic steatohepatitis (NASH). The secondary outcomes were the development of (1) cirrhosis and (2) NAFLD or NASH. Propensity score for anti-TNF-α agent use was generated by logistic regression. Cox proportional hazard models adjusting for the propensity score were used with regard to time-varying anti-TNF-α agent exposure. Results This study included 226 555 incident patients with immune-related diseases. During the median 1.5 years follow-up, there was an increased hazard with anti-TNF-α agent use in regard to liver outcomes (composite outcome HR: 1.47, 95% CI 1.27 to 1.70; cirrhosis HR 1.47, 95% CI 0.96 to 2.23; NAFLD or NASH HR 1.53, 95% CI 1.32 to 1.77). The composite outcome hazard was increased for each immune-related disease (HR 1.25–1.90). Conclusion In the short term, we did not observe a beneficial effect of anti-TNF-α agent use for development of cirrhosis, NAFLD or NASH in patients with immune-related diseases.

Verified
Journal Article
Open access
PDF file
PCPo-Ku Chen
Po-Ku Chen
KTKuo-Tung Tang
Kuo-Tung Tang
Der-Yuan ChenDer-Yuan Chen
Der-Yuan Chen
Rheumatoid arthritis (RA) is an autoimmune inflammatory disease characterized by chronic synovitis and the progressive destruction of cartilage and bone. RA is commonly accompanied by extra-articular comorbidities. The pathogenesis of RA and its comorbidities is complex and not completely elucidated. The assembly of the NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome activates caspase-1, which induces the maturation of interleukin (IL)-1β and IL-18 and leads to the cleavage of gasdermin D with promoting pyroptosis. Accumulative evidence indicates the pathogenic role of NLRP3 inflammasome signaling in RA and its comorbidities, including atherosclerotic cardiovascular disease, osteoporosis, and interstitial lung diseases. Although the available therapeutic agents are effective for RA treatment, their high cost and increased infection rate are causes for concern. Recent evidence revealed the components of the NLRP3 inflammasome as potential therapeutic targets in RA and its comorbidities. In this review, we searched the MEDLINE database using the PubMed interface and reviewed English-language literature on the NLRP3 inflammasome in RA and its comorbidities from 2000 to 2023. The current evidence reveals that the NLRP3 inflammasome contributes to the pathogenesis of RA and its comorbidities. Consequently, the components of the NLRP3 inflammasome signaling pathway represent promising therapeutic targets, and ongoing research might lead to the development of new, effective treatments for RA and its comorbidities.

1 April 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
KTKuo-Tung Tang
Kuo-Tung Tang
BHBo-Chueh Hsu
Bo-Chueh Hsu
DCDer-Yuan Chen
Der-Yuan Chen
Background: Vaccination is one of the most important measures worldwide to halt the spread of the corona virus disease 2019 (COVID-19). However, the efficacy and safety of these vaccines in rheumatic patients are not well explored. Therefore, we conducted a systematic review and meta-analysis. Methods: We performed a literature search of the PubMed and EMBASE databases on 17 November 2021. Forty-seven studies relevant to the immunogenicity, efficacy/effectiveness, and safety of COVID-19 vaccines were selected. Results: Our results demonstrated that COVID-19 vaccination is effective in protecting rheumatic patients from severe illness caused by the virus. Both the humoral and cellular immunogenicity of vaccines were impaired in rheumatic patients, which were greatly enhanced after the second vaccine dose. Receiving anti-CD20 therapy was associated with impaired humoral immunogenicity. Adverse events due to COVID-19 vaccines in rheumatic patients were similar to those in healthy controls, except for an increased incidence of arthralgia. The incidence of disease flares after COVID-19 vaccination was low. Conclusion: Our systematic review indicated the importance of full vaccination in rheumatic patients. Withholding anti-CD20 therapy was found to be potentially beneficial for the immunogenicity. Furthermore, the vaccines were found to be safe in general. Despite significant heterogeneity between studies, we recommend that rheumatic patients receive these vaccines amidst the global pandemic.

6 June 2018 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
KTKuo-Tung Tang
Kuo-Tung Tang
CTChien‐Hua Tseng
Chien‐Hua Tseng
THTsu‐Yi Hsieh
Tsu‐Yi Hsieh
Der-Yuan ChenDer-Yuan Chen
Der-Yuan Chen

1 September 2019 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
KTKuo-Tung Tang
Kuo-Tung Tang
BTBen-Jei Tsuang
Ben-Jei Tsuang
KKKai-Chen Ku
Kai-Chen Ku
YCYi-Hsing Chen
Yi-Hsing Chen
CLChing-Heng Lin
Ching-Heng Lin
Der-Yuan ChenDer-Yuan Chen
Der-Yuan Chen
Air pollutants are a heterogeneous mixture of gases and particles including particulate matter <2.5 µm in size (PM2.5), particulate matter <10 µm in size (PM10), nitrogen dioxide (NO2), carbon monoxide (CO), sulfur dioxide (SO2) and ozone (O3). Air pollutants have proinflammatory effects and are therefore among the environmental factors contributing to the generation of inflammation and autoimmunity. However, there is scanty data supporting the correlation between air pollution and systemic autoimmune rheumatic diseases (SARDs), which mainly include systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), systemic sclerosis and autoimmune myositis. We investigated the relationship between air pollutants exposure and SARDs in a nationwide population-based case–control study. From the National Health Insurance Research Database, we identified Chinese adult incident cases afflicted with one of SARDs as well as age-matched and gender-matched controls in a 1:4 ratio from 1 January 2012 to 31 December 2013 (table 1). Long-term residential exposure to air pollutants was estimated based on the monitoring data from Environmental Protection Agency in 2011. …